海吉亞醫療(06078.HK)回升9% 里昂指下行風險有限
海吉亞醫療(06078.HK)上日(12日)急跌22%後,今日(13日)高開0.6%,最高見36.5元,升9.28%。現報36.3元,升8.68%,成交427.4萬股,涉資1.52億元。
公司隔晚(12日)發聲明,強調業務經營狀況良好,經營和財務狀況沒有重大不利變化,並有信心保持其核心業務-醫院業務的持續發展。
里昂指,該股上日被拋售,提供買入機會,明年基本面能見度應較高,下行風險有限,重申「買入」評級,目標價由63元下調至49元。至於美銀就將目標價下調至50.4元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.